Farida Djouad1, Lars Rackwitz, Yingjie Song, Sasa Janjanin, Rocky S Tuan. 1. Cartilage Biology and Orthopaedics Branch, National Institute of Arthritis, and Musculoskeletal and Skin Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892-8022, USA.
Abstract
OBJECTIVE: Proinflammatory cytokines are known to provoke degradative signaling cascades that promote extracellular matrix disintegration in articular cartilage. Because integration of the repair tissue into the surrounding native cartilage to produce a mechanically stable interface has a profound impact on the viability and functionality of the restored joint surface, this study examined the effects of proinflammatory cytokines on the properties of tissue-engineered cartilage in the context of integration. METHODS: Using an established in vitro cartilage defect model, we examined the integration of chondrocyte-laden agarose constructs into native articular cartilage and the biochemical and biomechanical alterations of these implants upon treatment with interleukin 1-beta (IL1-beta) and tumor necrosis factor-alpha (TNF-alpha). Additionally, we probed extracellular regulated kinase (ERK) signaling involvement in response to proinflammatory cytokines. RESULTS: The time-dependent accumulation of extracellular matrix and concomitant increase in Young's modulus observed in the absence of cytokines was significantly decreased upon IL1-beta and TNF-alpha treatment. Push-out test showed the highest interface strength in hybrid cultures maintained without cytokines, which was significantly lowered with IL1-beta and TNF-alpha treatment. Histological characteristics of the interface region are consistent with the biochemical findings. Treatment with an inhibitor of ERK pathway antagonized the deleterious effects caused by both cytokines. CONCLUSION: This study is the first to show the functional catastrophic effects of IL1-beta and TNF-alpha on the biochemical, structural, and integrative properties of tissue-engineered cartilage and their significant counteraction by the blockade of ERK signaling pathway. With the discovery of new potential chemical entities, ERK inhibitor may emerge as a new therapeutic approach for functional integration and mechanical integrity of an engineered cartilage to the host tissue and, therefore, enhance long-term viability and functionality of the restored joint surface.
OBJECTIVE: Proinflammatory cytokines are known to provoke degradative signaling cascades that promote extracellular matrix disintegration in articular cartilage. Because integration of the repair tissue into the surrounding native cartilage to produce a mechanically stable interface has a profound impact on the viability and functionality of the restored joint surface, this study examined the effects of proinflammatory cytokines on the properties of tissue-engineered cartilage in the context of integration. METHODS: Using an established in vitro cartilage defect model, we examined the integration of chondrocyte-laden agarose constructs into native articular cartilage and the biochemical and biomechanical alterations of these implants upon treatment with interleukin 1-beta (IL1-beta) and tumor necrosis factor-alpha (TNF-alpha). Additionally, we probed extracellular regulated kinase (ERK) signaling involvement in response to proinflammatory cytokines. RESULTS: The time-dependent accumulation of extracellular matrix and concomitant increase in Young's modulus observed in the absence of cytokines was significantly decreased upon IL1-beta and TNF-alpha treatment. Push-out test showed the highest interface strength in hybrid cultures maintained without cytokines, which was significantly lowered with IL1-beta and TNF-alpha treatment. Histological characteristics of the interface region are consistent with the biochemical findings. Treatment with an inhibitor of ERK pathway antagonized the deleterious effects caused by both cytokines. CONCLUSION: This study is the first to show the functional catastrophic effects of IL1-beta and TNF-alpha on the biochemical, structural, and integrative properties of tissue-engineered cartilage and their significant counteraction by the blockade of ERK signaling pathway. With the discovery of new potential chemical entities, ERK inhibitor may emerge as a new therapeutic approach for functional integration and mechanical integrity of an engineered cartilage to the host tissue and, therefore, enhance long-term viability and functionality of the restored joint surface.
Authors: A P Kuruvilla; R Shah; G M Hochwald; H D Liggitt; M A Palladino; G J Thorbecke Journal: Proc Natl Acad Sci U S A Date: 1991-04-01 Impact factor: 11.205
Authors: Bhavana Mohanraj; Alice H Huang; Meira J Yeger-McKeever; Megan J Schmidt; George R Dodge; Robert L Mauck Journal: J Orthop Res Date: 2018-07-13 Impact factor: 3.494
Authors: Robert M Stefani; Andy J Lee; Andrea R Tan; Saiti S Halder; Yizhong Hu; X Edward Guo; Aaron M Stoker; Gerard A Ateshian; Kacey G Marra; James L Cook; Clark T Hung Journal: Acta Biomater Date: 2019-12-02 Impact factor: 8.947
Authors: Hang Lin; Anthony Wai-Ming Cheng; Peter G Alexander; Angela M Beck; Rocky S Tuan Journal: Tissue Eng Part A Date: 2014-04-09 Impact factor: 3.845
Authors: Lili Sheng; Prasant Kumar Jena; Ying Hu; Hui-Xin Liu; Nidhi Nagar; Karen M Kalanetra; Samuel William French; Samuel Wheeler French; David A Mills; Yu-Jui Yvonne Wan Journal: J Pathol Date: 2017-11-01 Impact factor: 7.996
Authors: Nicole Nadlonek; Joon H Lee; T Brett Reece; Michael J Weyant; Joseph C Cleveland; Xianzhong Meng; David A Fullerton Journal: Ann Thorac Surg Date: 2013-06-02 Impact factor: 4.330